Astrocytic Slc4a4 Regulates Blood-brain Barrier Integrity in Healthy and Stroke Brains Via a CCL2-CCR2 Pathway and NO Dysregulation
Overview
Cell Biology
Molecular Biology
Authors
Affiliations
Astrocytes play vital roles in blood-brain barrier (BBB) maintenance, yet how they support BBB integrity under normal or pathological conditions remains poorly defined. Recent evidence suggests that ion homeostasis is a cellular mechanism important for BBB integrity. In the current study, we investigated the function of an astrocyte-specific pH regulator, Slc4a4, in BBB maintenance and repair. We show that astrocytic Slc4a4 is required for normal astrocyte morphological complexity and BBB function. Multi-omics analyses identified increased astrocytic secretion of CCL2 coupled with dysregulated arginine-NO metabolism after Slc4a4 deletion. Using a model of ischemic stroke, we found that loss of Slc4a4 exacerbates BBB disruption, which was rescued by pharmacological or genetic inhibition of the CCL2-CCR2 pathway in vivo. Together, our study identifies the astrocytic Slc4a4-CCL2 and endothelial CCR2 axis as a mechanism controlling BBB integrity and repair, while providing insights for a therapeutic approach against BBB-related CNS disorders.
Dolutegravir induces endoplasmic reticulum stress at the blood-brain barrier.
Huang C, Qu Q, Hoque M, Bendayan R FASEB J. 2025; 39(4):e70377.
PMID: 39985305 PMC: 11846018. DOI: 10.1096/fj.202402677RR.
Castro-Martinez J, Vargas E, Diaz-Beltran L, Esteban F Curr Issues Mol Biol. 2024; 46(12):13583-13606.
PMID: 39727940 PMC: 11726880. DOI: 10.3390/cimb46120812.
The Involvement of Glial Cells in Blood-Brain Barrier Damage in Neuroimmune Diseases.
Nagata S, Yamasaki R Int J Mol Sci. 2024; 25(22).
PMID: 39596390 PMC: 11594741. DOI: 10.3390/ijms252212323.
pH regulating mechanisms of astrocytes: A critical component in physiology and disease of the brain.
Theparambil S, Begum G, Rose C Cell Calcium. 2024; 120:102882.
PMID: 38631162 PMC: 11423562. DOI: 10.1016/j.ceca.2024.102882.
Reshetnyak Y, Andreev O, Engelman D Front Pharmacol. 2024; 15:1355893.
PMID: 38545547 PMC: 10965573. DOI: 10.3389/fphar.2024.1355893.